@article{b47cfa7da6d4467ab4746d46df0d46a0,
title = "Psychopharmacology in Japan",
author = "Kazunari Yoshida and Takefumi Suzuki and Hiroyuki Uchida",
note = "Funding Information: Dr Yoshida has received manuscript fees or speaker's honoraria from Sumitomo Dainippon Pharma and Eli Lilly, fellowship grants from the Japan Research Foundation for Clinical Pharmacology, and consultant fees from Bracket within the past 3 years. Dr Suzuki has received manuscript or speaker's fees from Astellas, Dainippon Sumitomo Pharma, Eli Lilly, Elsevier Japan, Janssen Pharmaceuticals, Meiji Seika Pharma, Novartis, Otsuka Pharmaceutical, Wiley Japan, and Yoshitomi Yakuhin, and research grants from Eisai, Mochida Pharmaceutical, and Meiji Seika Pharma within the past 3 years. Dr Uchida has received grants from Eisai, Otsuka Pharmaceutical, Dainippon-Sumitomo Pharma, Mochida Pharmaceutical, Meiji-Seika Pharmaceutical, and Novartis; speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, Pfizer, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, MSD, and Janssen Pharmaceutical; and advisory panel payments from Dainippon-Sumitomo Pharma within the past 3 years.",
year = "2018",
month = oct,
day = "1",
doi = "10.1097/JCP.0000000000000932",
language = "English",
volume = "38",
pages = "415--419",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "5",
}
